Ongoing trials of cardiac resynchronisation

Minerva Cardioangiologica

Volumn 51, Issue 2, 2003, Pages 197-207

  Cleland, J G F ^a,b   Ghosh, J ^a   Khan, N ^a   Hurren, S ^a   Kaye, G ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

Cardiac pacing, artificial; Defibrillators, implantable; Heart failure, congestive

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE; DISEASE MARKER; ELECTROCARDIOGRAM; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE DIASTOLIC FUNCTION; HEART PACING; HUMAN; IATROGENIC DISEASE; IMPLANT; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PROGNOSIS; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL; REVIEW; SINUS RHYTHM; SUDDEN DEATH; TREATMENT FAILURE; TREATMENT INDICATION;

DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE, CONGESTIVE; HUMANS; PACEMAKER, ARTIFICIAL; RANDOMIZED CONTROLLED TRIALS;

EID: 0037675722     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. Cardiac resynchronisation in chronic heart failure. N Engl J Med 2002;346:1845-53.
2. Cazeau S, Leclerc C, Lavergne T, Walker S, Varma C, Linde C et al. Effects of multisite biventricular pacing in patients with hear failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80.
3. Coletta A, Louis AA, Clark AL, Nikitin N, Cleland JG. Clinical trials update from the European Society of Cardiology: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF. Eur J Heart Fail 2002;4:661-6.
4. Coletta AP, Thackray S, Nikitin N, Cleland JGF. Clinical Trials Update: highlights of the scientific sessions of the American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1&2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL. Eur J Heart Fail 2002;4:381-8.
5. Thackray S, Coletta A, Jones P, Dunn A, Clark AL, Cleland JGF. Clinical trials update: highlights of the scientific sessions of heart failure 2001, a meeting of the working group on heart failure of the European society of cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF. Eur J Heart Fail 2001;3:491-4.
6. Witte K, Thackray S, Clark A, Cooklin M, Cleland JGF. Clinical trials update. IMPROVEMENT-HF, COPERNICUS, MUSTIC, ASPECT-II and APRICOT. Eur J Heart Fail 2000;2:455-61.
7. Cleland JGF, Kappenberger LJ, Tavazzi L, Klein W, Erdmann E. Design and methodology of the CARE-HF trial. A randomised trial of cardiac resynchronisation in patients with heart failure and ventricular dyssynchrony. Eur J Heart Fail 2001;3:481-9.
8. Khan N, Louis AA, de Silva R, Witte KKA, Follath F, Komajda M et al. The EuroHeart Failure Survey: the value of the ECG in the Evaluation of heart failure [abstract]. Eur Heart J 2002;23:36-7.
9. Adamson PB, St John Sutton MG, Plappert T, Abraham WT, Hilpisch KE, Hill MSR. Echo-defined ventricular dyssynchrony predicts magnitude of response to cardiac desynchronisation [abstract]. J Card Fail 2002;8:S50.
10. Cleland JGF, Thackray S, Goodge L, Kaye GC, Cooklin M. Outcome studies with device therapy in patients with heart failure. J Cardiovasc Electrophysiol 2002;13:S73-91.
11. Farwell D, Patel NR, Hall A, Ralph S, Sulke AN. How many people with heart failure are appropriate for biventricular resynchronization? Eur Heart J 2000;21:1246-50.
12. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33.
13. Duncan A, Wait D, Gibson DG, Daubert J-C. Left ventricular remodelling and haemodynamic effects of multisite biventricular pacing in patients with congestive heart failure and activation disturbances: results from the MUSTIC study [abstract]. Eur Heart J. In press 2003.
14. Young JB, Abraham WT, Leon AR, Smith AL, Wilkoff BL, Hannon CH. Cardiac resynchronisation improves functional status in patients with ventricular dyssynchrony and an ICD indication: results from the MIRACLE ICD trial. J Card Fail 2002;8:S50.
15. Pavia SP, Perez-Lugones A, Lam C, Dresing T, Cole C, Abreu M et al. Symptomatic deterioration pastdual chamber cardioverter-defibrillator implantation: a retrospective, observational study [abstract]. J Am Coll Cardiol 2001;37 Suppl A:89A.
16. Lechat P, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 2001;103:1428-33.
17. Cleland JGF, Bristow M, Erdmann E, Remme WJ, Swedberg K, Waagstein F. β-blocking agents in heart failure. Should they be used and how? Eur Heart J 1996;17:1629-39.
18. Brecker SJD, Xiao HB, Sparrow J, Gibson DG. Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet 1992;340:1308-12.
19. Hochleitner M, Hortnagl H, Ng CK, Gschnitzer F, Zechmann W. Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol 1990;66:198-202.
20. Sack S, Franz R, Dagres N, Oldenburg O, Herrmann J, Golles A. Can right-sided atrioventricular sequential pacing provide benefit for selected patients with severe congestive heart failure? Am J Cardiol 1999;83 Suppl 5B:124D-9.
21. Linde C, Gadler F, Edner M, Nordlander R, Rosenqvist M, Ryden L. Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am J Cardiol 1995;75:919-23.
22. Gold MR, Feliciano Z, Gottlieb SS, Fisher ML. Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study. J Am Coll Cardiol 1995;26:967-73.
23. Saxon LA, Stevenson WG, Middlekauff HR, Stevenson LW. Increased risk of progressive hemodynamic deterioration in advanced heart failure patients requiring permanent pacemakers. Am Heart J 1993;125:1306-10.
24. Andersen HR, Nielsen JC, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350:1210-6.
25. Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PE et al. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 1994;344:1523-8.
26. Bristow MR, Feldman AM, Saxon LA. Heart failure management using implantable devices for ventricular resynchronization: comparison of medical therapy, pacing and defibrillation in chronic heart failure (COMPANION) Trial. Companion Steering Committee and Companion Clinical Investigators. J Card Fail 2000;6:276-85.
27. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. For the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
28. Cleland JGF, Ghosh J, Khan NK, Ghio S, Tavazzi L, Kaye G. Multi-chamber pacing: a perfect solution for cardiac mechanical dyssynchrony? Eur Heart J 2003; in press.
29. Wilkoff BL. Should all patients receive dual chamber pacing ICDs? The rationale for the DAVID trial. Curr Control Trials Cardiovasc Med 2001;2:215-7.
30. a. The DAVID Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. The dual chamber and VVI implantable defibrillator (DAVID) trial. JAMA 2002;288:3115-23.
31. Thackray SDR, Owen E, Witte K, Cooklin M, Clark AC, Cleland JGF. The prevalence of heart failure in the permanently paced population [abstract]. Eur J Heart Fail 2001;3:S112.
32. Tavazzi L. Ventricular pacing: a promising new therapeutic strategy in heart failure. Eur Heart J 2000;21:1211-4.
33. Sogaard P, Egeblad H, Kim WY, Jensen HK, Pedersen AK, Kristensen BOMPT. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol 2002;40:723-30.